We are live on ! Find out more
XENT

Intersect ENT, Inc

Delisted

XENT was delisted on the 12th of May, 2022.

115 hedge funds and large institutions have $528M invested in Intersect ENT, Inc in 2015 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 44 increasing their positions, 39 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 39

2% more capital invested

Capital invested by funds: $518M → $528M (+$9.49M)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0% more call options, than puts

Call options by funds: $1.13M | Put options by funds: $1.13M

8% less funds holding

Funds holding: 125115 (-10)

37% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 27

Holders
115
Holders Change
-10
Holders Change %
-8%
% of All Funds
3.02%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
17
Increased
44
Reduced
39
Closed
27
Calls
$1.13M
Puts
$1.13M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
FCMI
26
Foresite Capital Management III
California
$4.5M +$3.95M +200,000 New
NFA
27
Nationwide Fund Advisors
Ohio
$4.47M +$1.91M +96,794 +95%
PCM
28
Palisade Capital Management
New Jersey
$4.27M +$341K +17,227 +10%
JP Morgan Chase
29
JP Morgan Chase
New York
$3.91M -$2.06M -104,233 -37%
Thrivent Financial for Lutherans
30
Thrivent Financial for Lutherans
Minnesota
$3.54M +$3.11M +157,353 New
William Blair & Company
31
William Blair & Company
Illinois
$3.11M -$9.11K -461 -0.3%
Ameriprise
32
Ameriprise
Minnesota
$3.1M -$4.27M -215,766 -61%
D.E. Shaw & Co
33
D.E. Shaw & Co
New York
$2.92M -$1.07M -53,955 -29%
CCM
34
Cadian Capital Management
New York
$2.7M
Geode Capital Management
35
Geode Capital Management
Massachusetts
$2.63M +$28.9K +1,460 +1%
DCM
36
Driehaus Capital Management
Illinois
$2.34M -$2.39M -121,044 -54%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$2.28M -$638K -32,287 -24%
VAM
38
Visium Asset Management
New York
$2.25M +$1.98M +100,000 New
MOACM
39
Mutual of America Capital Management
New York
$2.08M +$797K +40,311 +78%
USAA
40
United Services Automobile Association
Texas
$1.89M +$972K +49,160 +142%
KCM
41
Kornitzer Capital Management
Kansas
$1.88M +$87K +4,400 +6%
Bank of America
42
Bank of America
North Carolina
$1.86M -$230K -11,649 -12%
Macquarie Group
43
Macquarie Group
Australia
$1.61M +$324K +16,381 +30%
GC
44
Gratus Capital
Georgia
$1.53M +$68K +3,440 +5%
QI
45
QS Investors
New York
$1.53M +$816K +41,284 +155%
GPCM
46
Granite Point Capital Management
Massachusetts
$1.52M -$2.62M -132,500 -66%
FG
47
Formula Growth
Quebec, Canada
$1.46M +$1.28M +64,813 New
Invesco
48
Invesco
Georgia
$1.44M -$9.57K -484 -0.8%
Goldman Sachs
49
Goldman Sachs
New York
$1.43M +$1.26M +63,665 New
Mackenzie Financial
50
Mackenzie Financial
Ontario, Canada
$1.42M +$440K +22,236 +55%

XENT Hedge Fund Activity: Q4 2015 in Review

115 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q4 2015, worth a combined $528M — up 1.8% from $518M a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of XENT and 17 opened new positions — a net loss of 10 holders — while 39 trimmed existing stakes and 44 added.

The largest buyer was Wellington Management Group, adding an estimated $37.6M. The largest seller was Lord, Abbett & Co, exiting entirely with an estimated $25.3M sold.

  • 115 institutional investors held Intersect ENT, Inc (XENT) as of Q4 2015, down from 125 in Q3 2015.
  • Funds reported $528M of Intersect ENT, Inc stock for Q4 2015, up 1.8% quarter-over-quarter.
  • 17 funds opened new Intersect ENT, Inc positions in Q4 2015 and 27 closed out, a net change of -10 holders.
  • The largest Intersect ENT, Inc buyer in Q4 2015 was Wellington Management Group, an estimated $37.6M added.
  • The largest Intersect ENT, Inc seller in Q4 2015 was Lord, Abbett & Co, an estimated $25.3M sold.

Based on aggregated 13F filings for Q4 2015.